Drug recall · May 9, 2018
Docetaxel injection concentrate recall
Why: Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been distributed.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business of Sanofi-Aventis U.S. LLC., NDC 0955-1020-01
- Lots / codes
Lot #: 7F307A, 7F307C, Exp 01/2019
- Quantity
- 19580 vials
- Company
- Sanofi-Aventis U.S. LLC, Bridgewater, NJ
- Distribution
- US nationwide
- Initiated
- April 27, 2018 · Voluntary: Firm initiated
- Classified
- May 14, 2018
- Reported
- May 9, 2018
- Ended
- January 20, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Docetaxel
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.